Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jiedu Tongluo Huashi Decoction is a traditional Chinese medicine (TCM) herbal formula used primarily for the treatment of chronic diseases characterized by "dampness," "toxicity," and impaired circulation according to TCM theory. While specific details about the exact composition of this decoction are not provided in the search results, similar formulas under the "Jiedu Tongluo" name have been studied for their effects on diabetic kidney disease, myocardial fibrosis, and other chronic inflammatory or fibrotic conditions[1][3][9]. Mechanistically, these formulas act through multi-target pathways including inhibition of TGF-β1/Smad2/3 signaling and Rho-associated protein kinase (ROCK) pathways to reduce fibrosis and inflammation[3][9]. The decoction is typically composed of multiple herbs with purported actions such as clearing heat/toxins, promoting blood circulation, removing dampness, and supporting organ function. It is not a single pharmaceutical agent but rather a complex mixture prepared according to TCM principles.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jiedu Tongluo Huashi Decoction.